79 related articles for article (PubMed ID: 3335005)
1. Tumorigenicity of murine lymphomas selected through fluorescence-detected natural antibody binding.
Tough DF; Chow DA
Cancer Res; 1988 Jan; 48(2):270-5. PubMed ID: 3335005
[TBL] [Abstract][Full Text] [Related]
2. Tumor progression in vitro: the paradoxical natural antibody and complement-selected phenotype.
Chow DA; Chan J
Nat Immun Cell Growth Regul; 1987; 6(4):189-204. PubMed ID: 3683415
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic alterations in tumors that developed from threshold subcutaneous inocula. I. Reduced binding of natural antibodies and sensitivity to hypotonic lysis.
Brown GW; Lesiuk TP; Chow DA
J Immunol; 1986 Apr; 136(8):3116-23. PubMed ID: 3958491
[TBL] [Abstract][Full Text] [Related]
4. Tumor selection in vivo for reduced sensitivity to natural resistance and natural antibodies.
Chow DA
J Natl Cancer Inst; 1984 Feb; 72(2):339-46. PubMed ID: 6582320
[TBL] [Abstract][Full Text] [Related]
5. Differential CD45 isoform expression accompanies reduced natural antibody binding in L5178Y-F9 tumor progression.
Zhang ZY; Chow DA
J Immunol; 1997 Jul; 159(1):344-50. PubMed ID: 9200472
[TBL] [Abstract][Full Text] [Related]
6. Polyclonal natural antitumor antibody binding dynamics: preferential release of surface membrane molecules and increased metastasis.
Chow DA; Yuan XY; Tough DF
Invasion Metastasis; 1992; 12(3-4):218-32. PubMed ID: 1294533
[TBL] [Abstract][Full Text] [Related]
7. Inverse correlation between natural antitumor antibodies and tumor susceptibility in individual xid-bearing mice.
Bennet RD; Chow DA
Nat Immun Cell Growth Regul; 1991; 10(1):45-55. PubMed ID: 2057021
[TBL] [Abstract][Full Text] [Related]
8. p21ras independent down-regulation of ras-induced increases in natural antibody binding during tumor progression.
Tough DF; Feng X; Chow DA
Nat Immun; 1995; 14(1):20-34. PubMed ID: 7599459
[TBL] [Abstract][Full Text] [Related]
9. Tumor progression in vitro: tumor-promoter-induced reversible decrease in natural immune susceptibility.
Sandstrom PA; Chow DA
Carcinogenesis; 1988 Nov; 9(11):1967-73. PubMed ID: 3180334
[TBL] [Abstract][Full Text] [Related]
10. Genetics, regulation, and specificity of murine natural antitumor antibodies and natural killer cells.
Chow DA; Wolosin LB; Greenberg AH
J Natl Cancer Inst; 1981 Aug; 67(2):445-53. PubMed ID: 6943381
[TBL] [Abstract][Full Text] [Related]
11. Phorbol ester tumor promoter regulation of natural antitumor antibody binding depends on protein kinase C and an intact microfilament system.
Sandstrom PA; Chow DA
Nat Immun; 1994; 13(6):331-43. PubMed ID: 7894203
[TBL] [Abstract][Full Text] [Related]
12. Comparison between murine natural antibodies and natural killer cells: recognition of separate target structures as revealed by differential in vitro expression and dependence on glycosylation.
Grönberg A; Eriksson E; Sinangil F; Rönnholm M; Feizi T; Minden P; Kiessling R
J Natl Cancer Inst; 1985 Jan; 74(1):67-75. PubMed ID: 2982055
[TBL] [Abstract][Full Text] [Related]
13. Natural resistance to tumors is a heterogeneous immunological phenomenon. Evidence for non-NK cell mechanisms.
Chow DA; Miller VE; Carlson GA; Pohajdak B; Greenberg AH
Invasion Metastasis; 1981; 1(4):205-19. PubMed ID: 6203863
[TBL] [Abstract][Full Text] [Related]
14. Tumor progression in vivo: increased soybean agglutinin lectin binding, N-acetylgalactosamine-specific lectin expression, and liver metastasis potential.
Reese MR; Chow DA
Cancer Res; 1992 Oct; 52(19):5235-43. PubMed ID: 1394127
[TBL] [Abstract][Full Text] [Related]
15. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
16. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
[TBL] [Abstract][Full Text] [Related]
17. An oligosaccharide biosynthetic defect in concanavalin A-resistant Chinese hamster ovary (CHO) cells that enhances NK reactivity in vitro and in vivo.
Pohajdak B; Wright JA; Greenberg AJ
J Immunol; 1984 Nov; 133(5):2423-9. PubMed ID: 6481160
[TBL] [Abstract][Full Text] [Related]
18. Reactivity of human natural antibodies to endothelial cells from Galalpha(1,3)Gal-deficient pigs.
Baumann BC; Stussi G; Huggel K; Rieben R; Seebach JD
Transplantation; 2007 Jan; 83(2):193-201. PubMed ID: 17264816
[TBL] [Abstract][Full Text] [Related]
19. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
Johnson PW; Trimble WS; Hozumi N; Roder JC
J Immunol; 1987 Jun; 138(11):3996-4003. PubMed ID: 3495578
[TBL] [Abstract][Full Text] [Related]
20. Murine natural antitumor antibodies. III. Interferon treatment of a natural killer-resistant lymphoma: augmentation of natural antibody reactivity and susceptibility to in vivo natural resistance.
Miller VE; Pohajdak B; Greenberg AH
J Natl Cancer Inst; 1983 Aug; 71(2):377-84. PubMed ID: 6576195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
